Contact
Wilbert S. Aronow, M.D., has edited more than 20 books and is the author or co-author of 2,000+ papers, more than 200 chapters in 100+ books, nearly 1,000 commentaries, 50 Letters to the Editor, 1,200+ abstracts, and is a presenter or co-presenter of more than 1,600 talks at meetings. Dr. Aronow has been a member of almost 200 editorial boards of medical journals. He has been a member of 4 national guidelines committees including being a coauthor of the 2010 AMDA guidelines for heart failure, a co-chair and first author of the 2011 ACC/AHA expert consensus document on hypertension in the elderly, a coauthor of the 2015 AHA/ACC/ASH scientific statement on treatment of hypertension in patients with coronary artery disease, and a coauthor of the 2017 ACC/AHA guidelines for the management of patients with hypertension. He was a co-author of a 2015 position paper from the International Lipid Expert Forum. Dr. Aronow has been a committee member of numerous professional societies and a consultant to many government agencies. He has mentored more than 1,200 physicians and medical students, as well as has 1,600+ papers listed on PubMed during his professional career.
Education
- Fellowship: Cardiology
- Residency: Internal Medicine
- M.D., Harvard Medical School
Areas of Expertise
- Cardiovascular Disease
- Preventive Cardiology
Honors and Awards
- 90 Honors including NYMC Chancellor's Research Award
- 2 NYMC 2021 Excellence in Teaching Dean's Faculty Award
- NYMC library 2024 Award for mentoring residents
Publications
- Naseem M, Ramesh J, Mahmood A, et. al. "Antiphospholipid Syndrome and Cardiovascular Disease." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001275
- Thukral J, Moudgil P, Sindhwani N, et. al. "Exosomes and Extracellular Vesicles in CAR-T Cell Therapy: Emerging Mediators and Biomarkers of Cardiac Injury." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001246
- Ji T, Frishman WH, Aronow WS, et. al. "Upstream Antiplatelet Therapy in ST-Segment Elevation Myocardial Infarction: What Zalunfiban Adds to the Glycoprotein IIb/IIIa Story." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001276
- Venkatesh V, Frishman WH, Aronow WS, et. al. "Raynaud's Disease: Review of Current Literature." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001278
- Adrejiya P, Bhatt V, Khushalani S, et. al. "The Changing Pulse of a Region: Ischemic Heart Disease and Its Drivers in the Asia-Pacific, 1990-2021." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001202
- Neshat N, Frishman WH, Aronow WS, et. al. "Caffeine and Cardiovascular Outcomes: Current Evidence and Clinical Perspectives." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001252
- AlSejari NY, Gadelmawla AF, Alfehaid A, et. al. "Sacubitril/Valsartan Versus Enalapril in Chagas Cardiomyopathy With Heart Failure: A Systematic Review and Meta-Analysis." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001270
Memberships and Affiliations
- FACC
- FAHA
- FACP
- FCCP
- FASPC
- AGSF
- FGSA
Teaching Responsibilities
- Mentor cardiology fellows
- Mentor medical residents
- Mentor medical students
